The genetic therapy is based on aldehyde dehydrogenase, a group of enzymes that metabolise
alcohol and are thus responsible for
alcohol tolerance, said Juan Asenjo, who heads a team of researchers at Chile's Faculty of Sciences and Mathematics and the private lab Recalcine.
About 20 per cent of the Asian population lacks this enzyme and thus experience "such a strong reaction that it discourages consumption," he added.